Independent Portfolio Consultants’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.01M Buy
11,416
+681
+6% +$57.4K 0.42% 49
2017
Q1
$865K Buy
10,735
+127
+1% +$9.92K 0.3% 104
2016
Q4
$756K Buy
10,608
+2,681
+34% +$211K 0.25% 146
2016
Q3
$685K Sell
7,927
-755
-9% -$65.8K 0.21% 169
2016
Q2
$753K Buy
8,682
+20
+0.2% +$1.62K 0.24% 132
2016
Q1
$650K Buy
8,662
+1,793
+26% +$135K 0.18% 168
2015
Q4
$528K Sell
6,869
-7,940
-54% -$598K 0.16% 188
2015
Q3
$991K Sell
14,809
-4,410
-23% -$325K 0.22% 135
2015
Q2
$1.42M Buy
+19,219
New +$1.47M 0.28% 121
2015
Q1
Sell
-17,759
Closed -$1.28M 1025
2014
Q4
$1.28M Buy
17,759
+10,196
+135% +$708K 0.26% 134
2014
Q3
$469K Buy
7,563
+3,008
+66% +$191K 0.13% 234
2014
Q2
$290K Buy
4,555
+130
+3% +$7.9K 0.08% 377
2014
Q1
$272K Sell
4,425
-720
-14% -$41.9K 0.09% 385
2013
Q4
$295K Buy
+5,145
New +$292K 0.1% 370

Other funds holding MDT

Independent Portfolio Consultants's MDT Position: Q2 2017 in Review

Independent Portfolio Consultants increased its Medtronic (MDT) stake by 6.3% in Q2 2017, buying an estimated $57.4K and bringing the position to 11,416 shares worth $1.01M. The position accounts for 0.42% of the portfolio, ranked #49.

Independent Portfolio Consultants first reported a position in MDT in Q4 2013 and has held it in 14 quarters since. The position peaked at $1.42M in Q2 2015. 1,281 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Independent Portfolio Consultants held 11,416 shares of Medtronic worth $1.01M as of Q2 2017.
  • Independent Portfolio Consultants bought 681 Medtronic shares in Q2 2017, an estimated $57.4K.
  • Medtronic made up 0.42% of Independent Portfolio Consultants's portfolio in Q2 2017, its #49 holding.
  • Independent Portfolio Consultants first reported a position in Medtronic in Q4 2013 and has held it in 14 quarters since.
  • Independent Portfolio Consultants's Medtronic position peaked at $1.42M in Q2 2015.
  • 1,281 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.